Tag: sexually transmitted disease self-testing market

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Sexually Transmitted Disease (STD) Self-Testing Market Expansion Outlook: What Revenue Opportunities Are Ahead?

The sexually transmitted disease (std) self-testing market size has experienced robust growth in recent years. It is projected to increase from $1.52 billion in 2025 to $1.67 billion in 2026, growing at a compound annual growth rate (CAGR) of 9.9%. The market’s expansion in the past can be attributed to several factors, including insufficient awareness regarding STD testing, the social stigma linked to visiting clinics, a reliance on hospital-based testing, a scarcity of convenient testing alternatives, and the rising incidence of sexually transmitted diseases.

The sexually transmitted disease (std) self-testing market size is projected to experience robust expansion over the coming years. This market is set to reach $2.42 billion in 2030, showing a compound annual growth rate (CAGR) of 9.7%. This projected growth is primarily driven by the increasing adoption of digital health platforms, the integration of multi-sample at-home testing kits, escalating government awareness initiatives, a rise in telehealth consultations, and the ongoing development of rapid and accurate diagnostic technologies. Key trends during this forecast period include a growing demand for at-home std testing kits, heightened awareness of sexual health and the benefits of early diagnosis, an expansion in telehealth and remote consultation services, the broadening of online and retail pharmacy distribution channels, and the integration of multi-sample testing solutions (blood, urine, oral).

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=56817556&type=smp&name=Sexually%20Transmitted%20Disease%20%28STD%29%20Self-Testing%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Sexually Transmitted Disease (STD) Self-Testing Market Growth Backed By Core Demand Fundamentals

The sexually transmitted disease (STD) self-testing market is anticipated to expand due to the increasing occurrence of syphilis. Syphilis, a sexually transmitted infection, manifests as body sores and can result in severe health problems if left untreated. Its rise is linked to reduced consistent condom usage, particularly among populations engaging in high-risk sexual behaviors. At-home STD self-testing offers a discreet and convenient method for syphilis screening, facilitating prompt identification. Such early detection ensures timely treatment, thereby lessening complications and hindering its continued transmission. For example, data from the Centers for Disease Control and Prevention, a US-based government agency, indicated around 209,253 syphilis cases in 2023, marking a 1% rise from 207,269 cases in 2022, according to figures released in September 2025. Consequently, the increasing prevalence of syphilis is a key factor propelling the expansion of the sexually transmitted disease (STD) self-testing market.

Sexually Transmitted Disease (STD) Self-Testing Market Segment Analysis: What Are The Core Market Categories?

The sexually transmitted disease (std) self-testing market covered in this report is segmented –

1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test

2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications

Subsegments:

1) By Blood-Based Test: Fingerstick Blood Sample, Dried Blood Spot (DBS) Sample, Capillary Blood Collection Device

2) By Urine-Based Test: First-Catch Urine Sample, Midstream Urine Sample, Preservative-Added Urine Collection

3) By Oral-Based Test: Oral Swab Sample, Oral Fluid Collection Device, Gumline Swab Collection

Sexually Transmitted Disease (STD) Self-Testing Market Growth Trends Reshaping The Competitive Landscape

Key entities within the STD self-testing market are prioritizing the development of advanced offerings, such as over-the-counter (OTC) sample collection kits, to encourage early identification and timely management of infections. Over-the-counter sample collection kits function as home diagnostic tools, enabling individuals to gather samples like urine or swabs without needing a prescription. They provide a convenient and private means for early infection detection, facilitating prompt treatment. For instance, in August 2023, iHealth Labs Inc., a US-based digital health company, introduced the CheckMeSafe home collection kit for HIV and syphilis testing. This FDA-approved kit permits individuals aged 18 and older to collect blood samples for HIV (I, II, P24 antigen) and syphilis testing from the convenience and privacy of their homes. Users are able to mail their samples to the laboratory using a prepaid overnight label and receive confidential, reliable results in as little as two days. The kit offers highly accurate results, demonstrating sensitivity rates of up to 99.9% for HIV and 99.5% for syphilis. All samples undergo analysis in a CLIA-certified and CAP-accredited laboratory, which ensures adherence to rigorous federal and state quality benchmarks through consistent inspections.

Sexually Transmitted Disease (STD) Self-Testing Market Top Companies Driving Competitive Growth

Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.

View The Full Sexually Transmitted Disease (STD) Self-Testing Market Report:

https://thebusinessresearchcompany.com/report/sexually-transmitted-disease-std-self-testing-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Sexually Transmitted Disease (STD) Self-Testing Market Regional Distribution: Which Areas Power Market Growth?

North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted disease (std) self-testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Sexually Transmitted Disease (STD) Self-Testing Market CAGR Analysis And Future Market Development

The market for self-testing kits targeting sexually transmitted diseases (STDs) has experienced robust expansion in recent years. Projected figures indicate it will rise from $1.52 billion in 2025 to $1.67 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.9%. This historical growth has been driven by factors such as insufficient knowledge regarding STD testing, the social stigma linked to visiting healthcare facilities, a dependence on hospital-centered diagnostics, an absence of accessible testing methods, and the increasing prevalence of sexually transmitted infections.

The sexually transmitted disease (STD) self-testing market is projected to experience significant expansion over the coming years. By 2030, its value is anticipated to reach $2.42 billion, representing a compound annual growth rate (CAGR) of 9.7%. This forecasted growth is driven by factors such as the rising use of digital health platforms, the introduction of multi-sample at-home testing kits, heightened government-led awareness initiatives, an increase in telehealth consultations, and the advancement of rapid and precise diagnostic technologies. Key trends influencing this period include a growing preference for at-home STD testing kits, greater awareness around sexual health and early detection, the expansion of telehealth and remote consultation services, the widening availability of these products through online and retail pharmacy channels, and the integration of multi-sample testing solutions that cover blood and urine samples.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25901&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Sexually Transmitted Disease (STD) Self-Testing Market Demand Drivers: What Is Fueling Industry Growth?

The growing frequency of syphilis infections is anticipated to accelerate expansion within the sexually transmitted disease (STD) self-testing market in the coming period. Syphilis, a sexually transmitted infection that manifests as bodily sores, may result in severe health complications when left untreated. Its prevalence is climbing due to reduced regular condom usage, especially among individuals involved in high-risk sexual activities. STD self-testing offers a confidential and practical method for conducting at-home syphilis screening, which facilitates earlier diagnosis. This timely identification supports immediate treatment, lessening the risk of complications and curbing further transmission. For example, in September 2025, the Centers for Disease Control and Prevention, a government agency based in the United States, reported approximately 209,253 syphilis cases in 2023, reflecting a 1% rise compared to 207,269 cases in 2022. Consequently, the increasing occurrence of syphilis is fueling growth in the STD self-testing market.

Sexually Transmitted Disease (STD) Self-Testing Market Segments: Where Are The Largest Growth Opportunities?

The sexually transmitted disease (std) self-testing market covered in this report is segmented –

1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test

2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications

Subsegments:

1) By Blood-Based Test: Fingerstick Blood Sample, Dried Blood Spot (DBS) Sample, Capillary Blood Collection Device

2) By Urine-Based Test: First-Catch Urine Sample, Midstream Urine Sample, Preservative-Added Urine Collection

3) By Oral-Based Test: Oral Swab Sample, Oral Fluid Collection Device, Gumline Swab Collection

Sexually Transmitted Disease (STD) Self-Testing Market Innovation Trends: Which Developments Are Transforming The Industry?

Major players within the STD self-testing industry are prioritizing the creation of advanced diagnostic tools, including over-the-counter (OTC) sample collection kits, aimed at facilitating early infection detection and encouraging timely therapeutic interventions. These OTC collection kits are at-home diagnostic tools that enable individuals to obtain samples—such as urine or swabs—without requiring a medical prescription. They offer a convenient and private means of spotting infections at an early stage, thereby making quick treatment possible. As an example, iHealth Labs Inc., a digital health company based in the United States, introduced the CheckMeSafe home collection kit for HIV and syphilis testing in August 2023. This FDA-endorsed kit is designed for individuals aged 18 and older, allowing them to collect blood specimens for detecting HIV (including types I, II, and P24 antigen) and syphilis, all from the security and privacy of their own residence. Users can send their collected samples to a laboratory using a provided prepaid overnight shipping label, with confidential and dependable results delivered in as little as two days. The kit boasts exceptional accuracy, with sensitivity rates reaching 99.9% for HIV and 99.5% for syphilis. Every sample undergoes analysis in a laboratory that holds both CLIA certification and CAP accreditation, ensuring strict adherence to rigorous federal and state quality standards through routine assessments.

Sexually Transmitted Disease (STD) Self-Testing Market Major Participants And Competitive Dynamics

Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.

Access The Complete Sexually Transmitted Disease (STD) Self-Testing Market Report:

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-disease-std-self-testing-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Sexually Transmitted Disease (STD) Self-Testing Market Geographic Landscape: Which Region Dominates Industry Growth?

North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted disease (std) self-testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Sexually Transmitted Disease (STD) Self-Testing Market CAGR Analysis And Future Market Development

The market for self-testing kits targeting sexually transmitted diseases (STDs) has experienced robust expansion in recent years. Projected figures indicate it will rise from $1.52 billion in 2025 to $1.67 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.9%. This historical growth has been driven by factors such as insufficient knowledge regarding STD testing, the social stigma linked to visiting healthcare facilities, a dependence on hospital-centered diagnostics, an absence of accessible testing methods, and the increasing prevalence of sexually transmitted infections.

The sexually transmitted disease (STD) self-testing market is projected to experience significant expansion over the coming years. By 2030, its value is anticipated to reach $2.42 billion, representing a compound annual growth rate (CAGR) of 9.7%. This forecasted growth is driven by factors such as the rising use of digital health platforms, the introduction of multi-sample at-home testing kits, heightened government-led awareness initiatives, an increase in telehealth consultations, and the advancement of rapid and precise diagnostic technologies. Key trends influencing this period include a growing preference for at-home STD testing kits, greater awareness around sexual health and early detection, the expansion of telehealth and remote consultation services, the widening availability of these products through online and retail pharmacy channels, and the integration of multi-sample testing solutions that cover blood and urine samples.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25901&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Sexually Transmitted Disease (STD) Self-Testing Market Demand Drivers: What Is Fueling Industry Growth?

The growing frequency of syphilis infections is anticipated to accelerate expansion within the sexually transmitted disease (STD) self-testing market in the coming period. Syphilis, a sexually transmitted infection that manifests as bodily sores, may result in severe health complications when left untreated. Its prevalence is climbing due to reduced regular condom usage, especially among individuals involved in high-risk sexual activities. STD self-testing offers a confidential and practical method for conducting at-home syphilis screening, which facilitates earlier diagnosis. This timely identification supports immediate treatment, lessening the risk of complications and curbing further transmission. For example, in September 2025, the Centers for Disease Control and Prevention, a government agency based in the United States, reported approximately 209,253 syphilis cases in 2023, reflecting a 1% rise compared to 207,269 cases in 2022. Consequently, the increasing occurrence of syphilis is fueling growth in the STD self-testing market.

Sexually Transmitted Disease (STD) Self-Testing Market Segments: Where Are The Largest Growth Opportunities?

The sexually transmitted disease (std) self-testing market covered in this report is segmented –

1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test

2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications

Subsegments:

1) By Blood-Based Test: Fingerstick Blood Sample, Dried Blood Spot (DBS) Sample, Capillary Blood Collection Device

2) By Urine-Based Test: First-Catch Urine Sample, Midstream Urine Sample, Preservative-Added Urine Collection

3) By Oral-Based Test: Oral Swab Sample, Oral Fluid Collection Device, Gumline Swab Collection

Sexually Transmitted Disease (STD) Self-Testing Market Innovation Trends: Which Developments Are Transforming The Industry?

Major players within the STD self-testing industry are prioritizing the creation of advanced diagnostic tools, including over-the-counter (OTC) sample collection kits, aimed at facilitating early infection detection and encouraging timely therapeutic interventions. These OTC collection kits are at-home diagnostic tools that enable individuals to obtain samples—such as urine or swabs—without requiring a medical prescription. They offer a convenient and private means of spotting infections at an early stage, thereby making quick treatment possible. As an example, iHealth Labs Inc., a digital health company based in the United States, introduced the CheckMeSafe home collection kit for HIV and syphilis testing in August 2023. This FDA-endorsed kit is designed for individuals aged 18 and older, allowing them to collect blood specimens for detecting HIV (including types I, II, and P24 antigen) and syphilis, all from the security and privacy of their own residence. Users can send their collected samples to a laboratory using a provided prepaid overnight shipping label, with confidential and dependable results delivered in as little as two days. The kit boasts exceptional accuracy, with sensitivity rates reaching 99.9% for HIV and 99.5% for syphilis. Every sample undergoes analysis in a laboratory that holds both CLIA certification and CAP accreditation, ensuring strict adherence to rigorous federal and state quality standards through routine assessments.

Sexually Transmitted Disease (STD) Self-Testing Market Major Participants And Competitive Dynamics

Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.

Access The Complete Sexually Transmitted Disease (STD) Self-Testing Market Report:

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-disease-std-self-testing-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Sexually Transmitted Disease (STD) Self-Testing Market Geographic Landscape: Which Region Dominates Industry Growth?

North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted disease (std) self-testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Size Of The Sexually Transmitted Disease (STD) Self-Testing Market In 2026 And How Much Will It Reach By 2030?

The sexually transmitted disease (std) self-testing market has demonstrated significant expansion in recent years. Its valuation is anticipated to climb from $1.52 billion in 2025 to $1.67 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. The primary drivers for this historical increase include insufficient public understanding of std testing, the social stigma associated with attending clinics, an over-reliance on hospital-based testing, a scarcity of convenient testing options, and the increasing occurrence of sexually transmitted diseases.

The sexually transmitted disease (std) self-testing market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $2.42 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.7%. This anticipated growth is driven by several factors, including the increasing use of digital health platforms, the introduction of multi-sample at-home testing kits, enhanced government initiatives for awareness, a rise in telehealth consultations, and advancements in rapid and precise diagnostic technologies. Key trends expected during this period involve a surge in demand for at-home std testing kits, greater public consciousness regarding sexual health and the benefits of early diagnosis, the expansion of telehealth and remote consultation services, the widening of online and retail pharmacy distribution networks, and the incorporation of multi-sample testing solutions (covering blood, urine, and oral samples).

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25901&type=smp

What Important Drivers Are Powering The Sexually Transmitted Disease (STD) Self-Testing Market Growth?

The increasing occurrence of syphilis is projected to drive expansion within the sexually transmitted disease (STD) self-testing market. Syphilis, a sexually transmitted infection, manifests as bodily sores and can result in severe health issues without proper treatment. The rise in syphilis cases stems from a decrease in regular condom usage, especially among individuals involved in high-risk sexual activities. STD self-testing offers a discreet and convenient way to screen for syphilis at home, facilitating prompt diagnosis. Such early detection leads to timely treatment, thereby reducing complications and inhibiting broader transmission. As an illustration, in September 2025, the Centers for Disease Control and Prevention, a US-based government agency, indicated approximately 209,253 syphilis cases were reported in 2023, marking a 1% increase from 207,269 cases in 2022. Consequently, the escalating number of syphilis cases is fueling the growth of the sexually transmitted disease (STD) self-testing market.

Which Segment Groups Define The Sexually Transmitted Disease (STD) Self-Testing Market Landscape?

The sexually transmitted disease (std) self-testing market covered in this report is segmented –

1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test

2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications

Subsegments:

1) By Blood-Based Test: Fingerstick Blood Sample, Dried Blood Spot (DBS) Sample, Capillary Blood Collection Device

2) By Urine-Based Test: First-Catch Urine Sample, Midstream Urine Sample, Preservative-Added Urine Collection

3) By Oral-Based Test: Oral Swab Sample, Oral Fluid Collection Device, Gumline Swab Collection

What Trends Are Influencing The Sexually Transmitted Disease (STD) Self-Testing Market?

Leading companies within the STD self-testing market are concentrating on developing advanced products, such as over-the-counter (OTC) sample collection kits, to encourage early detection and timely treatment of infections. Over-the-counter sample collection kits function as at-home diagnostic tools, enabling individuals to gather samples like urine or swabs without requiring a prescription. They offer a convenient and confidential method for detecting infections early and facilitating prompt treatment. For instance, in August 2023, iHealth Labs Inc., a US-based digital health company, introduced the CheckMeSafe home collection kit for HIV and syphilis testing. This FDA-approved kit permits individuals aged 18 and older to collect blood samples for HIV (I, II, P24 antigen) and syphilis testing from the comfort and privacy of their own home. Users can dispatch their samples to the lab using a prepaid overnight label and receive confidential, reliable results in as little as two days. The kit delivers highly accurate results, featuring sensitivity rates of up to 99.9% for HIV and 99.5% for syphilis. All samples are processed in a CLIA-certified and CAP-accredited laboratory, ensuring compliance with strict federal and state quality standards through regular inspections.

Which Firms Are Competing In The Sexually Transmitted Disease (STD) Self-Testing Market?

Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.

Access The Complete Sexually Transmitted Disease (STD) Self-Testing Market Report:

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-disease-std-self-testing-global-market-report

Which Region Holds The Largest Share In The Sexually Transmitted Disease (STD) Self-Testing Market?

North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted disease (std) self-testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Sexually Transmitted Disease (STD) Self-Testing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=25901&type=smp

Browse Through More Reports Similar to the Global Sexually Transmitted Disease (STD) Self-Testing Market 2026, By The Business Research Company

Std Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

Sexually Transmitted Infections Stis Market Report 2026

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

Chlamydia Trachomatis Ct And Neisseria Gonorrhoeae Ng Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/chlamydia-trachomatis-ct-and-neisseria-gonorrhoeae-ng-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Sexually Transmitted Disease (STD) Self-Testing Market From 2026 To 2030?

The sexually transmitted disease (std) self-testing market has experienced robust growth in recent years. Projections indicate it will expand from $1.52 billion in 2025 to reach $1.67 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 9.9%. Historically, this growth can be ascribed to factors such as inadequate awareness regarding STD testing, the stigma linked with clinic visits, a dependence on hospital-based testing, the scarcity of accessible testing alternatives, and an increasing prevalence of sexually transmitted diseases.

The sexually transmitted disease (STD) self-testing market size is anticipated to experience robust growth in the coming years. It is projected to reach $2.42 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.7%. This expansion during the forecast period can be attributed to the uptake of digital health platforms, the integration of multi-sample at-home testing kits, increasing government awareness campaigns, a rise in telehealth consultations, and the development of rapid and accurate diagnostic technologies. Key trends in the forecast period include a growing demand for at-home STD testing kits, enhanced awareness of sexual health and the importance of early diagnosis, the growth of telehealth and remote consultation services, the expansion of online and retail pharmacy distribution channels, and the integration of multi-sample testing solutions (blood, urine, oral).

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25901&type=smp

Which Primary Drivers Are Impacting The Sexually Transmitted Disease (STD) Self-Testing Market Growth?

The escalating incidence of syphilis is anticipated to boost the growth of the sexually transmitted disease (STD) self-testing market moving forward. Syphilis, a sexually transmitted infection, causes body sores and can lead to severe health problems if left untreated. This increase in syphilis cases is linked to a decrease in consistent condom use, particularly among populations engaging in high-risk sexual behaviors. STD self-testing provides a private and convenient way for at-home syphilis screening, aiding in early diagnosis. This prompt detection ensures immediate treatment, thereby minimizing complications and preventing further spread. For instance, in September 2025, the Centers for Disease Control and Prevention, a US-based government agency, reported approximately 209,253 syphilis cases in 2023, marking a 1% rise from 207,269 cases in 2022. Thus, the growing occurrence of syphilis is driving the expansion of the sexually transmitted disease (STD) self-testing market.

Which Segment Classifications Are Used In The Sexually Transmitted Disease (STD) Self-Testing Market Segment Analysis?

The sexually transmitted disease (std) self-testing market covered in this report is segmented –

1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test

2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications

Subsegments:

1) By Blood-Based Test: Fingerstick Blood Sample, Dried Blood Spot (DBS) Sample, Capillary Blood Collection Device

2) By Urine-Based Test: First-Catch Urine Sample, Midstream Urine Sample, Preservative-Added Urine Collection

3) By Oral-Based Test: Oral Swab Sample, Oral Fluid Collection Device, Gumline Swab Collection

Which Trends Are Influencing Demand In The Sexually Transmitted Disease (STD) Self-Testing Market?

Leading businesses in the STD self-testing market are concentrating on creating sophisticated products, including over-the-counter (OTC) sample collection kits, with the aim of fostering early identification and prompt management of infections. These OTC kits serve as home-based diagnostic instruments, enabling people to gather samples like urine or swabs without requiring a doctor’s prescription. They offer a convenient and private method for early infection detection and facilitate swift treatment. An example of this is iHealth Labs Inc., a US-based digital health firm, which introduced the CheckMeSafe home collection kit for HIV and syphilis testing in August 2023. This FDA-approved kit permits individuals who are 18 and above to collect blood samples for HIV (I, II, P24 antigen) and syphilis testing within the comfort and confidentiality of their residences. Users are able to send their samples to the lab via a prepaid overnight label and obtain confidential, dependable results in as few as two days. The kit delivers highly precise outcomes, featuring sensitivity rates reaching 99.9% for HIV and 99.5% for syphilis. Every sample undergoes analysis in a CLIA-certified and CAP-accredited laboratory, thereby guaranteeing adherence to stringent federal and state quality benchmarks through consistent inspections.

Which Firms Are Contributing To The Sexually Transmitted Disease (STD) Self-Testing Market Ecosystem?

Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.

Get The Full Sexually Transmitted Disease (STD) Self-Testing Market Report:

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-disease-std-self-testing-global-market-report

Where Is The Sexually Transmitted Disease (STD) Self-Testing Market Most Concentrated Geographically?

North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted disease (std) self-testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Sexually Transmitted Disease (STD) Self-Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-disease-std-self-testing-global-market-report

Browse Through More Reports Similar to the Global Sexually Transmitted Disease (STD) Self-Testing Market 2026, By The Business Research Company

Std Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

Sexually Transmitted Infections Stis Market Report 2026

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

Chlamydia Trachomatis Ct And Neisseria Gonorrhoeae Ng Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/chlamydia-trachomatis-ct-and-neisseria-gonorrhoeae-ng-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Sexually Transmitted Disease (STD) Self-Testing Market From 2026 To 2030?

The sexually transmitted disease (std) self-testing market has experienced robust growth in recent years. Projections indicate it will expand from $1.52 billion in 2025 to reach $1.67 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 9.9%. Historically, this growth can be ascribed to factors such as inadequate awareness regarding STD testing, the stigma linked with clinic visits, a dependence on hospital-based testing, the scarcity of accessible testing alternatives, and an increasing prevalence of sexually transmitted diseases.

The sexually transmitted disease (STD) self-testing market size is anticipated to experience robust growth in the coming years. It is projected to reach $2.42 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.7%. This expansion during the forecast period can be attributed to the uptake of digital health platforms, the integration of multi-sample at-home testing kits, increasing government awareness campaigns, a rise in telehealth consultations, and the development of rapid and accurate diagnostic technologies. Key trends in the forecast period include a growing demand for at-home STD testing kits, enhanced awareness of sexual health and the importance of early diagnosis, the growth of telehealth and remote consultation services, the expansion of online and retail pharmacy distribution channels, and the integration of multi-sample testing solutions (blood, urine, oral).

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25901&type=smp

Which Primary Drivers Are Impacting The Sexually Transmitted Disease (STD) Self-Testing Market Growth?

The escalating incidence of syphilis is anticipated to boost the growth of the sexually transmitted disease (STD) self-testing market moving forward. Syphilis, a sexually transmitted infection, causes body sores and can lead to severe health problems if left untreated. This increase in syphilis cases is linked to a decrease in consistent condom use, particularly among populations engaging in high-risk sexual behaviors. STD self-testing provides a private and convenient way for at-home syphilis screening, aiding in early diagnosis. This prompt detection ensures immediate treatment, thereby minimizing complications and preventing further spread. For instance, in September 2025, the Centers for Disease Control and Prevention, a US-based government agency, reported approximately 209,253 syphilis cases in 2023, marking a 1% rise from 207,269 cases in 2022. Thus, the growing occurrence of syphilis is driving the expansion of the sexually transmitted disease (STD) self-testing market.

Which Segment Classifications Are Used In The Sexually Transmitted Disease (STD) Self-Testing Market Segment Analysis?

The sexually transmitted disease (std) self-testing market covered in this report is segmented –

1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test

2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications

Subsegments:

1) By Blood-Based Test: Fingerstick Blood Sample, Dried Blood Spot (DBS) Sample, Capillary Blood Collection Device

2) By Urine-Based Test: First-Catch Urine Sample, Midstream Urine Sample, Preservative-Added Urine Collection

3) By Oral-Based Test: Oral Swab Sample, Oral Fluid Collection Device, Gumline Swab Collection

Which Trends Are Influencing Demand In The Sexually Transmitted Disease (STD) Self-Testing Market?

Leading businesses in the STD self-testing market are concentrating on creating sophisticated products, including over-the-counter (OTC) sample collection kits, with the aim of fostering early identification and prompt management of infections. These OTC kits serve as home-based diagnostic instruments, enabling people to gather samples like urine or swabs without requiring a doctor’s prescription. They offer a convenient and private method for early infection detection and facilitate swift treatment. An example of this is iHealth Labs Inc., a US-based digital health firm, which introduced the CheckMeSafe home collection kit for HIV and syphilis testing in August 2023. This FDA-approved kit permits individuals who are 18 and above to collect blood samples for HIV (I, II, P24 antigen) and syphilis testing within the comfort and confidentiality of their residences. Users are able to send their samples to the lab via a prepaid overnight label and obtain confidential, dependable results in as few as two days. The kit delivers highly precise outcomes, featuring sensitivity rates reaching 99.9% for HIV and 99.5% for syphilis. Every sample undergoes analysis in a CLIA-certified and CAP-accredited laboratory, thereby guaranteeing adherence to stringent federal and state quality benchmarks through consistent inspections.

Which Firms Are Contributing To The Sexually Transmitted Disease (STD) Self-Testing Market Ecosystem?

Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.

Get The Full Sexually Transmitted Disease (STD) Self-Testing Market Report:

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-disease-std-self-testing-global-market-report

Where Is The Sexually Transmitted Disease (STD) Self-Testing Market Most Concentrated Geographically?

North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted disease (std) self-testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Sexually Transmitted Disease (STD) Self-Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-disease-std-self-testing-global-market-report

Browse Through More Reports Similar to the Global Sexually Transmitted Disease (STD) Self-Testing Market 2026, By The Business Research Company

Std Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

Sexually Transmitted Infections Stis Market Report 2026

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

Chlamydia Trachomatis Ct And Neisseria Gonorrhoeae Ng Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/chlamydia-trachomatis-ct-and-neisseria-gonorrhoeae-ng-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Sexually Transmitted Disease (STD) Self-Testing Market Over The Period 2026–2030?

The sexually transmitted disease (std) self-testing market has experienced considerable growth in recent years. This market is projected to expand from $1.52 billion in 2025 to $1.67 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 9.9%. The historic period’s growth can be ascribed to several factors, including limited awareness regarding std testing, the stigma associated with visiting clinics, a reliance on hospital-based testing, an absence of convenient testing options, and the increasing incidence of sexually transmitted diseases.

The sexually transmitted disease (std) self-testing market size is projected to experience substantial expansion over the coming years. This market is anticipated to reach a size of $2.42 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.7%. This anticipated growth during the forecast period is attributable to several factors, including the increasing adoption of digital health platforms, the integration of multi-sample at-home testing kits, escalating government awareness initiatives, a rise in telehealth consultations, and advancements in rapid and accurate diagnostic technologies. Key trends for this period encompass a growing demand for at-home STD testing kits, heightened awareness concerning sexual health and the importance of early diagnosis, the expansion of telehealth and remote consultation services, broader distribution through online and retail pharmacy channels, and the incorporation of multi-sample testing solutions (such as blood, urine, and oral samples).

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25901&type=smp

Which Major Factors Are Driving The Expansion Of The Sexually Transmitted Disease (STD) Self-Testing Market?

An increasing number of syphilis cases is anticipated to drive expansion in the sexually transmitted disease (STD) self-testing market in the future. Syphilis, a sexually transmitted infection, manifests as body sores and can result in severe health complications without proper treatment. This rise in syphilis can be attributed to a reduction in regular condom usage, especially within groups that engage in high-risk sexual activities. Sexually transmitted disease self-testing offers discreet and convenient at-home screening options for syphilis, thereby encouraging early detection. Such timely diagnosis facilitates swift treatment, which helps in reducing complications and halting further transmission. For instance, according to a report from the Centers for Disease Control and Prevention, a US-based government agency, expected around September 2025, roughly 209,253 syphilis cases were reported in 2023, signifying a 1% increase from 207,269 cases in 2022. Consequently, the escalating occurrence of syphilis is stimulating the expansion of the sexually transmitted disease (STD) self-testing market.

How Is The Sexually Transmitted Disease (STD) Self-Testing Market Divided Into Its Major Segments?

The sexually transmitted disease (std) self-testing market covered in this report is segmented –

1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test

2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications

Subsegments:

1) By Blood-Based Test: Fingerstick Blood Sample, Dried Blood Spot (DBS) Sample, Capillary Blood Collection Device

2) By Urine-Based Test: First-Catch Urine Sample, Midstream Urine Sample, Preservative-Added Urine Collection

3) By Oral-Based Test: Oral Swab Sample, Oral Fluid Collection Device, Gumline Swab Collection

How Are Trends Transforming The Sexually Transmitted Disease (STD) Self-Testing Market Landscape?

Major companies operating in the STD self-testing market are concentrating on developing advanced products, such as over-the-counter (OTC) sample collection kits, to promote early detection and timely treatment of infections. Over-the-counter sample collection kits serve as at-home diagnostic tools that enable individuals to collect samples like urine or swabs without needing a prescription. They offer a convenient and confidential way to identify infections early and facilitate prompt treatment. For instance, in August 2023, iHealth Labs Inc., a US-based digital health company, introduced the CheckMeSafe home collection kit for HIV and syphilis testing. This FDA-approved kit allows individuals aged 18 and older to collect blood samples for HIV (I, II, P24 antigen) and syphilis testing from the comfort and privacy of their own home. Users can mail their samples to the laboratory using a prepaid overnight label and receive confidential, reliable results in as little as two days. The kit provides highly accurate results, with sensitivity rates reaching up to 99.9% for HIV and 99.5% for syphilis. All samples are analyzed in a CLIA-certified and CAP-accredited laboratory, ensuring compliance with strict federal and state quality standards through regular inspections.

Who Are The Prominent Organizations Shaping The Sexually Transmitted Disease (STD) Self-Testing Market?

Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.

Read the full sexually transmitted disease (std) self-testing market report here:

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-disease-std-self-testing-global-market-report

Which Region Currently Holds The Largest Share Of The Sexually Transmitted Disease (STD) Self-Testing Market?

North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted disease (std) self-testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Sexually Transmitted Disease (STD) Self-Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25901&type=smp

Browse Through More Reports Similar to the Global Sexually Transmitted Disease (STD) Self-Testing Market 2026, By The Business Research Company

Std Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

Sexually Transmitted Infections Stis Market Report 2026

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

Chlamydia Trachomatis Ct And Neisseria Gonorrhoeae Ng Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/chlamydia-trachomatis-ct-and-neisseria-gonorrhoeae-ng-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the sexually transmitted disease (std) self-testing market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Sexually Transmitted Disease (STD) Self-Testing Market’s size between 2026 and 2030?

The sexually transmitted disease (std) self-testing market size has experienced substantial expansion in recent years. This market is forecasted to expand from $1.52 billion in 2025 to $1.67 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.9%. The growth observed in prior periods can be attributed to factors such as limited public awareness about std testing, the social stigma connected with clinic visits, a dependence on hospital-based testing facilities, the absence of accessible testing options, and an increasing occurrence of sexually transmitted diseases.

The market for sexually transmitted disease (STD) self-testing is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $2.42 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.7%. Key factors contributing to this projected growth include the widespread adoption of digital health platforms, the incorporation of multi-sample at-home testing kits, increased government initiatives for awareness, a rise in telehealth consultations, and advances in rapid and precise diagnostic technologies. Noteworthy trends expected during this period encompass a growing demand for at-home STD testing kits, enhanced public understanding of sexual health and the importance of early diagnosis, the expansion of telehealth and remote consultation services, broader availability through online and retail pharmacy distribution, and the incorporation of multi-sample testing options (such as blood, urine, and oral samples).

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25901&type=smp

Which Drivers Are Shaping Strategic Decisions In The Sexually Transmitted Disease (STD) Self-Testing Market?

An increasing occurrence of syphilis is projected to drive expansion within the sexually transmitted disease (STD) self-testing market in the future. Syphilis, an STI, manifests as bodily sores and can result in severe health complications if left untreated. The rise in syphilis cases is attributed to a reduction in regular condom usage, especially within groups participating in risky sexual activities. At-home STD self-testing offers a discreet and accessible way to screen for syphilis, thus encouraging prompt diagnosis. Such timely detection facilitates immediate treatment, thereby reducing complications and hindering its continued transmission. As an illustration, in September 2025, the Centers for Disease Control and Prevention, a US government agency, reported approximately 209,253 syphilis cases in 2023, marking a 1% rise from 207,269 cases recorded in 2022. Consequently, the growing frequency of syphilis cases is fueling the expansion of the sexually transmitted disease (STD) self-testing market.

What Segment Categories Are Covered In The Sexually Transmitted Disease (STD) Self-Testing Market?

The sexually transmitted disease (std) self-testing market covered in this report is segmented –

1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test

2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications

Subsegments:

1) By Blood-Based Test: Fingerstick Blood Sample, Dried Blood Spot (DBS) Sample, Capillary Blood Collection Device

2) By Urine-Based Test: First-Catch Urine Sample, Midstream Urine Sample, Preservative-Added Urine Collection

3) By Oral-Based Test: Oral Swab Sample, Oral Fluid Collection Device, Gumline Swab Collection

What Trends Are Expected To Impact The Competitive Landscape Of The Sexually Transmitted Disease (STD) Self-Testing Market?

Major companies operating in the STD self-testing market are prioritizing the development of advanced products, including over-the-counter (OTC) sample collection kits, to encourage early detection and timely treatment of infections. Over-the-counter sample collection kits serve as at-home diagnostic tools that enable individuals to collect samples, such as urine or swabs, without needing a prescription. These kits offer a convenient and confidential approach to identify infections early, facilitating prompt treatment. For instance, in August 2023, iHealth Labs Inc., a US-based digital health company, launched the CheckMeSafe home collection kit designed for HIV and syphilis testing. This FDA-approved kit permits individuals aged 18 and older to collect blood samples for HIV (I, II, P24 antigen) and syphilis testing from the comfort and privacy of their residence. Users can mail their samples to the laboratory using a prepaid overnight label and expect confidential, reliable results in as little as two days. The kit delivers highly accurate results, boasting sensitivity rates of up to 99.9% for HIV and 99.5% for syphilis. All samples are processed in a CLIA-certified and CAP-accredited laboratory, ensuring adherence to strict federal and state quality standards through routine inspections.

Which Leading Companies Dominate The Sexually Transmitted Disease (STD) Self-Testing Market Share?

Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-disease-std-self-testing-global-market-report

How Does The Sexually Transmitted Disease (STD) Self-Testing Market Perform Across Major Global Regions?

North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted disease (std) self-testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Sexually Transmitted Disease (STD) Self-Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25901&type=smp

Browse Through More Reports Similar to the Global Sexually Transmitted Disease (STD) Self-Testing Market 2026, By The Business Research Company

Std Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

Sexually Transmitted Infections Stis Market Report 2026

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

Chlamydia Trachomatis Ct And Neisseria Gonorrhoeae Ng Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/chlamydia-trachomatis-ct-and-neisseria-gonorrhoeae-ng-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Sexually Transmitted Disease (STD) Self-Testing Industry In 2025?

The market size for sexually transmitted disease (STD) self-testing has experienced rapid growth over the past few years. This market is projected to expand from $1.38 billion in 2024 to reach $1.52 billion by 2025, achieving a compound annual growth rate (CAGR) of 10.1%. Historically, this expansion has been driven by factors such as heightened awareness of sexual health, greater uptake of at-home healthcare options, an increase in government-sponsored STD screening programs, the growing availability of over-the-counter self-test kits, and heightened apprehension regarding privacy during clinic-based testing.

The sexually transmitted disease (STD) self-testing market is projected to experience substantial expansion in the coming years, with its size anticipated to reach $2.21 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.8%. This expansion throughout the forecast period is primarily driven by the increasing occurrence of sexually transmitted infections, a rising need for easy-to-use and confidential testing options, greater incorporation of digital health into self-test kits, wider availability of at-home diagnostics in developing regions, and the increasing authorization of sophisticated self-testing innovations by regulatory bodies. Key trends anticipated during this period encompass progress in rapid molecular diagnostic technologies, enhanced mobile application integration for tracking results, the creation of self-test kits capable of detecting multiple infections, novel approaches to discreet packaging and delivery, and improvements in AI-driven interpretation of test outcomes.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25901&type=smp

What Are The Top Growth Drivers Impacting The Sexually Transmitted Disease (STD) Self-Testing Market Outlook?

The increasing occurrence of syphilis is projected to stimulate the expansion of the sexually transmitted disease (STD) self-testing market moving forward. Syphilis is a sexually transmitted infection that causes lesions on the body and can lead to severe health issues if left untreated. The rise in syphilis cases is linked to a decrease in consistent condom usage, particularly among groups engaging in high-risk sexual activities. STD self-testing provides a discreet and convenient option for at-home screening for syphilis, encouraging prompt diagnosis. This early identification ensures timely intervention, reducing complications and preventing further spread. For example, according to the Centers for Disease Control and Prevention, a US-based government agency, approximately 209,253 syphilis cases were reported in 2023, marking a 1% increase from 207,269 cases in 2022. Thus, the escalating incidence of syphilis is a primary factor driving the growth of the sexually transmitted disease (STD) self-testing market.

What Are The Different Segment Classifications Within The Sexually Transmitted Disease (STD) Self-Testing Market?

The sexually transmitted disease (std) self-testing market covered in this report is segmented –

1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test

2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications

Subsegments:

1) By Blood-Based Test: Fingerstick Blood Sample, Dried Blood Spot (DBS) Sample, Capillary Blood Collection Device

2) By Urine-Based Test: First-Catch Urine Sample, Midstream Urine Sample, Preservative-Added Urine Collection

3) By Oral-Based Test: Oral Swab Sample, Oral Fluid Collection Device, Gumline Swab Collection

Which Competitive Trends Are Defining The Sexually Transmitted Disease (STD) Self-Testing Market Structure?

Leading companies in the STD self-testing market are concentrating on developing advanced products, such as over-the-counter (OTC) sample collection kits, to encourage early detection and timely treatment of infections. These OTC sample collection kits serve as at-home diagnostic tools, enabling individuals to gather samples like urine or swabs without needing a prescription. They provide a convenient and confidential method for early infection detection, thereby facilitating prompt treatment. For instance, in August 2023, iHealth Labs Inc., a US-based digital health company, introduced the CheckMeSafe home collection kit for HIV and syphilis testing. This FDA-approved kit allows individuals aged 18 and older to collect blood samples for HIV (I, II, P24 antigen) and syphilis testing from the comfort and privacy of their own homes. Users can mail their samples to the lab using a prepaid overnight label and receive confidential, reliable results in as little as two days. The kit offers highly accurate results, with sensitivity rates of up to 99.9% for HIV and 99.5% for syphilis. All samples undergo analysis in a CLIA-certified and CAP-accredited laboratory, ensuring compliance with strict federal and state quality standards through regular inspections.

Which Key Players Are Driving Competition In The Sexually Transmitted Disease (STD) Self-Testing Market?

Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-disease-std-self-testing-global-market-report

How Do Regional Market Performances Compare Within The Sexually Transmitted Disease (STD) Self-Testing Industry?

North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted disease (std) self-testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Sexually Transmitted Disease (STD) Self-Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25901&type=smp

Browse Through More Reports Similar to the Global Sexually Transmitted Disease (STD) Self-Testing Market 2025, By The Business Research Company

Std Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

Sexually Transmitted Infections Stis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

Chlamydia Trachomatis Ct And Neisseria Gonorrhoeae Ng Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chlamydia-trachomatis-ct-and-neisseria-gonorrhoeae-ng-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Sexually Transmitted Disease (STD) Self-Testing Market Be Worth By 2029?

The market size for self-testing of sexually transmitted diseases (STDs) has seen a significant increase in the recent past. From $1.38 billion in the year 2024, it is projected to reach $1.52 billion in the subsequent year, 2025, at a compound annual growth rate (CAGR) of 10.1%. The growth during the historic period can be attributed to an enhanced understanding of sexual health, an uptick in the adoption of healthcare solutions that can be utilized at home, an increase in government-sponsored STD screening initiatives, more availability of self-test kits that can be bought over-the-counter, and escalating concerns pertaining to privacy during testing in clinics.

The market size for self-testing of sexually transmitted diseases (STDs) is forecasted to experience notable growth in the near future, expanding to $2.21 billion by 2029 with a compound annual growth rate (CAGR) of 9.8%. The reasons for this growth in the predicted period include an uptick in sexual infection cases, a growing demand for private and convenient testing methods, more integration of digital health in self-testing kits, wider access to home diagnostic tests in developing markets, and regulatory bodies’ increasing approval of sophisticated self-testing techniques. Key trends anticipated in this forecast period encompass progress in speedy molecular diagnostic technologies, enhancements in mobile app integration for results monitoring, creation of self-testing kits for multiple infections, innovations in discreet delivery and packaging models, and advancements in AI-driven interpretation of test outcomes.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25901&type=smp

Which Key Factors Are Fueling Growth In The Sexually Transmitted Disease (STD) Self-Testing Market?

The escalating prevalence of syphilis is anticipated to drive the expansion of the sexually transmitted disease (STD) self-testing market. Syphilis, a sexually transmitted infection, leads to sores on the body and may result in substantial health issues if not addressed. The surge in Syphilis cases is due to the decrease in regular condom use, especially among groups involved in risky sexual practices. STD self-testing provides a confidential and convenient way to screen for syphilis at home, encouraging early detection. Timely detection guarantees swift treatment, reducing complications, and preventing additional spread. For example, about 209,253 syphilis cases were documented in 2023 as stated by the Centers for Disease Control and Prevention, a US government agency. This signifies a 1% growth from 207,269 cases in 2022. Consequently, the escalating prevalence of syphilis is steering the expansion of the sexually transmitted disease (STD) self-testing market.

Which Segmentation Factors Are Critical In The Sexually Transmitted Disease (STD) Self-Testing Market Analysis?

The sexually transmitted disease (std) self-testing market covered in this report is segmented –

1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test

2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications

Subsegments:

1) By Blood-Based Test: Fingerstick Blood Sample, Dried Blood Spot (DBS) Sample, Capillary Blood Collection Device

2) By Urine-Based Test: First-Catch Urine Sample, Midstream Urine Sample, Preservative-Added Urine Collection

3) By Oral-Based Test: Oral Swab Sample, Oral Fluid Collection Device, Gumline Swab Collection

What Are The Dominant Trends Currently Seen In The Sexually Transmitted Disease (STD) Self-Testing Market?

Leading corporations in the STD self-testing market are emphasizing on the development of advanced products such as over-the-counter (OTC) sample collection kits. These kits aim at fostering early detection and immediate treatment of infections. Over-the-counter sample collection kits serve as at-home diagnostic instruments that allow people to collect samples like urine or swabs without a prescription. They offer a private and convenient way to identify infections early and initiate quick treatment. For example, in August 2023, a US digital health firm named iHealth Labs Inc. introduced the CheckMeSafe home collection kit designed for HIV and syphilis testing. This FDA-approved kit is available for individuals 18 years and older, enabling them to collect blood samples for HIV (I, II, P24 antigen) and syphilis testing at home. Users can then send their samples back to the lab using a prepaid overnight label, with the expectation to receive secure, trustworthy results within two days. The kit possesses a high degree of accuracy, showcasing sensitivity rates reaching up to 99.9% and 99.5% for HIV and syphilis respectively. All samples undergo examination in a CLIA-certified and CAP-accredited lab, ensuring they meet strict federal and state quality standards through frequent inspections.

Which Players Are Shaping The Competitive Landscape Of The Sexually Transmitted Disease (STD) Self-Testing Market?

Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-disease-std-self-testing-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Sexually Transmitted Disease (STD) Self-Testing Market?

North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted disease (std) self-testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=25901&type=smp

Browse Through More Reports Similar to the Global Sexually Transmitted Disease (STD) Self-Testing Market 2025, By The Business Research Company

Self Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/self-testing-global-market-report

Chlamydia Infection Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chlamydia-infection-diagnostics-global-market-report

Infectious Disease Diagnostics Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

About The Business Research Company:

With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model